This manuscript explains how diabetes is a challenge for the society, the content in this manuscript is purely my opinion this is not statically proved one. 
The rapid growth of diabetes in the society is really a challenge to all the countries, in every country the policy makers of health should restructure their policies to fight the diabetes, according to WHO, total diabetes patients in world are nearly 422 million people, the majority people with diabetes, are from low and middle income countries [1].

According to the report, people from low and middle income countries are more affected with diabetes due to their poor health policy, there is only way to overcome is to restructure the policies and restructure the health system with the help of high income countries [2].

The other major cause for diabetes is due to unhealthy food habits, as this vary from country to country, we cannot specify the style which can be planned in all countries, its people, who need to take care of food which is the best and healthy which can be consumed for their healthy life style [3].

As per the records, there are nearly 1.6 million people fall in to death bed due to diabetes every year, the figure it self-shows how challenging the diabetes to overcome this life should be planned in a healthy way. Based on the other survey it shows the number of diabetic patients is increasing day by day [4].

The worldwide commonness of diabetes was accounted for to the world when the fifth version of the International Diabetes Federation (IDF) Atlas was delivered during World Diabetes Day, 14 November 2011. The quantity of individuals with diabetes was around 366 million of every 2011, and constantly 2030 this number has been anticipated to increment to 552 million. It is likewise assessed that around 80% of individuals with diabetes live in the low-and center pay nations, which are assigned as the creating economies on the planet [5]. China and India will bear the significant weight of diabetes, with an expected 129.7 and 101.2 million cases,Separately, by 2030. The biggest age bunch at present influenced by diabetes is the 40–59 years age gathering, and by 2030 this is required to move to the 60–79 years age gathering [6]. Furthermore, there will be a multiplying of pervasiveness of diabetes in the Middle East, north Africa, south Asia and sub-Saharan Africa. More than 1 million individuals bite the dust because of diabetes every year, 66% of these are in creating nations. Undiscovered diabetes represents 85% of those with diabetes in concentrates from South Africa, 80% in Cameroon, 70% in Ghana and over 80% in Tanzania [7]. 

In India, as in other low-and center pay nations, diabetes and different NCDs are generally eclipsed by the diligent weight of transmittable and nourishment related ailments. While these sicknesses are as yet present – albeit gradually diminishing – the ascent of NCDs has been somewhat quick. As indicated by the World Health Report 2005 [8-12], NCDs as of now add to 52% of the absolute mortality in India and this is required to increment to 69% continuously 2030. Thusly, nations, for example, India are right now confronting an epidemiologic change with a 'twofold weight' of ailment. According to the most recent IDF chart book, there were around 61.3 million individuals with diabetes in India, which will increment to in excess of 100 million by 2030. There is a touch of contention with respect to the pervasiveness of diabetes in India, since the greater part of the accessible information are gotten from a couple of dissipated examinations directed in various pieces of the nation [13-16]. Few multicentric contemplates are accessible, those distributed include: the Indian Council of Medical Research (ICMR) study directed during the 1970s, which revealed a commonness of 12–19% in urban regions and 4–10% in the rustic territories of India; the National Urban Diabetes Survey (NUDS), which announced a pervasiveness of over 12% among urban Indians; the Prevalence of Diabetes in India Study (PUDIS) that detailed a predominance of 5.9 and 2.7% among urban and country subjects, separately; and the WHO-ICMR NCD Risk Factor Surveillance study, which detailed more prominent than 11% pervasiveness of diabetes among urban Indians. Thus, there has been no national examination that has taken a gander at the predominance of diabetes in India in general, covering all the conditions of the nation or even in any single state with far reaching urban and country portrayal. All things considered, the accessible information positively give probably some important data on the predominance of diabetes in India [17-21]. For instance, an ongoing multicentric study announced the general predominance of diabetes to be 10.4% in Tamil Nadu, 8.4% in Maharashtra, 5.3% in Jharkhand and 13.6% in Chandigarh, with an altogether high pervasiveness rate in the urban settings contrasted and the provincial regions in these states. Another examination in the Ernakulam area of Kerala announced 20% commonness. Concerning commonness of diabetic entanglements, there are a few facility based and a couple of populace based investigations. Chennai Urban Rural Epidemiology Study (CURES) and Chennai Urban Population Study (CUPS) give populace put together information from India with respect to basically all inconveniences of diabetes. Fixes revealed a general pervasiveness of 17.6% diabetic retinopathy, 2.2% clear nephropathy and 26.9% miniaturized scale albuminuria. The pervasiveness of fringe neuropathy was accounted for to be 26.1%. Results from CUPS show that coronary supply route malady was seen in 21.4% of diabetic subjects and fringe vascular sickness in 6.3% of diabetic subjects.

1. Vijay Viswanathan, V Narayan Rao (2013) Problems associated with diabetes care In India, Diabetes Manage. 3(1), 31–40.
2. Mahendra Kumar Sahu, Vijay Kumar Singh, S. Prakash Rao (2018) Development and Evaluation of Antidiabetic Potential of Polyherbal Formulation in Streptozotocin Induced Animal Model, Diab Obes Metab Disor OA 4: 20-30.
3. Milind G. Ruke (2018) Management of diabetic foot and amputations due to diabetes: Role of prostheses and orthoses, Diab Obes Metab Disor OA 4: 16-19
4. Guilford BL, Leey JA ,Strassels SA, Rai A, Herndon CM (2018) Is Impaired Hypoglycemia Awareness Associated with Obstructive Sleep Apnea in Diabetic Patients?. Diab Obes Metab Disor OA 4: 16-23.
5. Siegel EG, Platten I, Kraft M , Lorenzo Bermejo J, Hasslacher C (2018) Composition of intestinal microbiome and barrier function in Type 2 diabetic patients and nondiabetic controls. Diab Obes Metab Disor OA 4: 10-15.
6. Alok Raghav, Jamal Ahmad (2018) Diabetes mellitus and foot ulcer: Always challenge to society. Diab Obes Metab Disor OA 4: 5-9
7. Francisco J. Sanchez-Muniz, Garcia Quismondo A, Del Canizo FJ (2018) C Reactive Protein And Obesity In Type 2 Diabetes Mellitus Patients From The Dicariva Study . Diab Obes Metab Disor OA 4: 1-4.
8. Ana Paulina Barba de la Rosa, Erik Elvin Gómez-Cardona, Eric Edmundo Hernández-Domìnguez, José Ángel Huerta-Ocampo, Hugo Jiménez-Islas etal., (2017) Effect of amaranth consumption on diabetes-related biomarkers in patients with diabetes Diab Obes Metab Disor OA 3: 5-10
9. Ying Hua Gao-Balch (2016) Nutrients with Binge Drinking in the College Students, Diab Obes Metab Disor OA 2: 47-49.
10. DeGeeter M, Williamson BJ, Meadowcraft LM (2016) A review of the current literature and guidance for treatment of the dawn phenomenon and glycemic variability, Diab Obes Metab Disor OA 2: 100115.
11. Khalida A (2016) Diabetes and Metabolic Disorders, a Study among Population of Adults in Tebessa (City of Eastern Algeria). Diab Obes Metab Disor OA 2: 100106.
12. Askari G (2016) The effect of anthocyanin supplementation on systolic and diastolic blood pressure and mean arterial pressure in athletes. Diab Obes Metab Disor OA 2: 100107.
13. Maghsoudi Z (2016) The effect of resveratrol supplementation on malondialdehyde, TNFα and interlukine-2 in elite female volleyball players. Diab Obes Metab Disor OA 2: 100108.
14. Ghiasvand R, Maghsoudi Z, Darvishi L, Shoaei T (2016) The effect of jujube powder on several digestive symptoms and C-reactive protein in patients with irritable bowel syndrome. Diab Obes Metab Disor OA 2: 100109.
15. Nourian M, Maghsoudi Z, Shirani F (2016) Assessment of mineral intake in Adolescent School Children of Isfahan. Diab Obes Metab Disor OA 2: 100110.
16. Maghsoudi Z, Foroughi M, Askari G (2016) The effect of vitamin D supplementation on body composition parameters in patients with non-alcoholic fatty liver disease (NAFLD). Diab Obes Metab Disor OA 2: 100111.
17. Kevin GC (2015) Diabetes: What the Past tells us about the Future. Diab Obes Metab Disor OA 1: 100101.
18. Latifi SM (2015) Efficiency of Anthropometric Indices in Predicting Metabolic Syndrome among Adult Population of Ahvaz, Iran. Diab Obes Metab Disor OA 1: 100102.
19. Dixit AK (2015) Let the Sunshine In: Therapeutic Prospects of Vitamin D in Diabetology. Diab Obes Metab Disor OA 1: 100103.
20. Fabiane Gomes de Moraes Rego (2016) Polymorphisms in the Fat Mass and Obesity Associated (FTO) and Transcription factor 7-like 2 (TCF7L2) genes in Euro-Brazilian individuals with type 2 diabetes. Diab Obes Metab Disor OA 2: 100104.
21. Maghsoudi Z (2016) The role of flax seed in prevention and management of diabetes mellitus type I and type II. Diab Obes Metab Disor OA 2: 100105.